With a global focus on strategies to curb expansion of a fast-moving coronavirus pandemic, the question again has arisen: What more is being done about HIV, a scourge that has lasted more than 40 years—is a cure finally ...
Peter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in fighting solid cancer tumors.
Apr 7, 2023
0
94
If you have ever smoked, or know someone who has—they might tell you that smoking a cigarette probably felt disgusting at first.
Nov 25, 2019
0
57
(Medical Xpress)—A number of lung diseases are resistant to, or only marginally handled by, conventional therapies. Thanks to the discovery of numerous genetic targets, gene therapy provides an alternative or complementary ...
Just over two years ago, Melinda Bachini decided she was done with chemotherapy to treat her cholangiocarcinoma—a rare cancer of the bile duct that runs from the liver to the intestines.
May 8, 2014
0
1
(Medical Xpress)—Cranial irradiation saves the lives of brain cancer patients. It slows cancer progression and increases survival rates. Unfortunately, patients who undergo cranial irradiation often develop problems with ...
University of Leeds researchers, funded by Cancer Research UK, have used a library of DNA to create a vaccine that could be used to treat cancer, according to a study published in Nature Medicine.
Jun 19, 2011
2
0
Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors—an advance ...
May 8, 2024
0
11
A study published in Nature Reviews Neuroscience by an international team including the Woolcock's Dr. Rick Wassing examined research into sleep disorders over more than two decades to prove a good night's sleep is the perfect ...
May 7, 2024
0
50
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two ...
May 3, 2024
0
52
